TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III

Cynthia X Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.